Isodiol International Inc. Signs Definitive Agreement to Acquire 100% Of Canadian National Pharma Group INC.

February 15, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has entered into a Definitive Agreement to acquire 100% of Canadian National Pharma Group Inc. (CN Pharma), a pharmaceutical manufacturing company. Isodiol …

ISODIOL INTERNATIONAL INC. ANNOUNCES PARTNERSHIP WITH EUROPE’S LEADING MMA PROMOTION, CAGE WARRIORS; ISO-SPORT PRODUCT LINE TO COMMENCE SALES IN THE EUROPEAN MARKET

February 12, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of wellness products, proudly announces that it has reached a partnership agreement with Cage Warriors, Europe’s leading Mixed Martial Arts (MMA) promotion through its brand ISO-Sport.  The Company will launch the European roll …

ISODIOL INTERNATIONAL INC. IS PROUD TO ANNOUNCE THE APPOINTMENT OF WINTER ATHLETE BRAND AMBASSADORS JAZMINE FENLATOR, KILEY MCKINNON, KIMANI GRIFFIN, FAYE GULINI, AND JULIA MARINO

February 8, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, announces that Jazmine Fenlator, Kiley McKinnon, Kimani Griffin, Faye Gulini, and Julia Marino have been appointed as brand ambassadors for ISO-Sport to demonstrate and discuss the health …

ISODIOL INTERNATIONAL INC. RECEIVES REGULATORY (ANVISA) APPROVAL FOR ISODIOLEX FOR THE TREATMENT OF EPILEPSY AND PARKINSON’S

February 5, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, announced today that it has received approval from the Brazilian Health Regulatory Agency (ANVISA) This product will be placed on the Special Category List for alternative therapies …

ISODIOL INTERNATIONAL INC. BRAND AMBASSADOR AND SPOKESMAN MARVIN WASHINGTON MAKING HEADWAYS ON CTE DISCUSSION AT SUPERBOWL LII

January 31, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, announces that Marvin Washington, brand ambassador and spokesman for ISO-Sport, has been speaking on multiple platforms to discuss and raise awareness surrounding the neurological disorder, Chronic Traumatic …

ISODIOL INTERNATIONAL INC. BRAND AMBASSADOR AND SPOKESMAN TO DISCUSS CTE AT SUPERBOWL LII

January 29, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, announced today that Marvin Washington, brand ambassador and spokesman for Isodiol, will be speaking on the cause of the neurological disorder Chronic Traumatic Encephalopathy (CTE) at Super …

ISODIOL INTERNATIONAL INC. ANNOUNCES LICENSING AGREEMENT WITH LIVECARE HEALTH CANADA INC. AND APPOINTS DR. AMIT MATHUR TO MEDICAL ADVISORY BOARD

January 26, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has signed a licensing agreement with Livecare Health Canada Inc. (Livecare), an organization founded and operated by Doctors dedicated to giving …

ISODIOL INTERNATIONAL INC. ANNOUNCES EXTENSION OF LICENSING AGREEMENT WITH KATHY IRELAND AND LEVEL BRANDS

Terms of License Agreement extended to 10 years, Territory expanded to worldwide January 22, 2018 – Vancouver, BC – Isodiol International Inc., (CSE: ISOL) (OTC:ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global bioactive phytoceutical innovator specializing in the development of pharmaceutical and wellness products, announced today that it has signed an amendment to the license agreement with Level Brands Inc. (NYSE …

Isodiol International Inc. Signs Letter of Intent to Acquire 100% of Green Island Naturals

January 12, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global bioactive phytoceutical innovator specializing in the development of pharmaceutical and wellness products, announced today that is has signed a Letter of Intent to acquire 100% of the CBD assets of Green Island Naturals. Green Island Naturals is a formulator, …

Isodiol International Inc. Signs Binding Supply Agreement with Namaste Technologies Inc.

January 12, 2017 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global bio-active phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has signed a binding agreement with Namaste Technologies Inc. (“Namaste”)(CNSX: N)(OTCBQ: NXTTF)(FRA: M5BQ), an online retailer for cannabis delivery systems globally. …